Hyperoside: A review on its sources, biological activities, and molecular mechanisms.

Qi Wang, Hao-Cheng Wei, Sheng-Jun Zhou, Ying Li, Ting-Ting Zheng, Chang-Zheng Zhou, Xin-Huan Wan

Journal: Phytotherapy research : PTR 2022;36(7):2779-2802

PMID: 35561084

Abstract

Hyperoside is a natural flavonol glycoside in various plants, such as Crataegus pinnatifida Bge, Forsythia suspensa, and Cuscuta chinensis Lam. Medical research has found that hyperoside possesses a broad spectrum of biological activities, including anticancer, anti-inflammatory, antibacterial, antiviral, antidepressant, and organ protective effects. These pharmacological properties lay the foundation for its use in treating multiple diseases, such as sepsis, arthritis, colitis, diabetic nephropathy, myocardial ischemia-reperfusion, pulmonary fibrosis, and cancers. Hyperoside is obtained from the plants and chemical synthesis. This study aims to provide a comprehensive overview of hyperoside on its sources and biological activities to provide insights into its therapeutic potential, and to provide a basis for high-quality studies to determine the clinical efficacy of this compound.

© 2022 John Wiley & Sons Ltd.

Address: College of Pharmacy, Shandong University of Traditional Chinese Medicine, Ji'nan, China.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.